Basit öÄŸe kaydını göster

dc.contributor.authorTugal-Tutkun, Ä°lknur
dc.contributor.authorAksu Ceylan, Nihan
dc.contributor.authorErgül, Elif
dc.contributor.authorOray, Merih
dc.date.accessioned2022-07-04T14:38:14Z
dc.date.available2022-07-04T14:38:14Z
dc.identifier.citationAksu Ceylan N., Ergül E., Oray M., Tugal-Tutkun Ä°., "Acute Idiopathic Hemorrhagic Retinal Vasculitis: Clinical Course and Treatment", International Ocular Inflammation Society 2021 Congress, 2 - 05 Aralık 2021, ss.5
dc.identifier.otherav_845fb2f5-f100-46c9-adf7-256bbf74dfef
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/183544
dc.description.abstractPurpose To report clinical characteristics and treatment of acute idiopathic hemorrhagicretinal vasculitis (AIHRV)Methods Records of 10 patients (7 female, 3 male) with AIHRV in 12 eyes seen between2012-2018 were reviewed.ResultsMean age at presentation was 32±5 years. Mean LogMAR visual acuity (VA) was1.5±0.8, mean intraocular pressure (IOP) was 10.8±3.3, mean Nare value was152.6±237.8ph/ms, mean central macular thickness (CMT) was 709.5±266.3􀀀 atpresentation. All patients had extensive preretinal and/or subretinalhemorrhages and vascular sheathing. Fluorescein angiography was performed in7 patients, showing retinal ischemia in 6 and neovascularization in 2 eyes.Serological tests, hematologic and rheumatologic examination were unrewardingin all. Mean follow-up was 13.5±9.9 months. 9 patients received systemiccorticosteroids. Adjunct local corticosteroids and/or intravitreal anti-VEGFinjections were performed when needed. 2 patients with macular edema receivedInterferon alpha-2a, 2 patients received empirical oral valacyclovir and 1 patientreceived azathioprine. Retinal laser photocoagulation was performed in 8 eyes.Ocular complications were vitreous hemorrhage in 2 and increased IOP in 8patients, including 2 with neovascular glaucoma. At [nal visit, mean LogMAR VAwas 0.8±0.8, mean IOP was 15.9±3.8, mean Nare was 22.8±30.9ph/ms, meanCMT was 272.7±70.8􀀀.ConclusionAIHRV is a challenging condition with unknown etiology and there is no speci[ctreatment. Close follow-up is required for early detection and treatment of ocularcomplications.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCERRAHÄ°
dc.subjectOFTALMOLOJÄ°
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectOphthalmology
dc.subjectOptometry
dc.subjectSurgery
dc.subjectHealth Sciences
dc.titleAcute Idiopathic Hemorrhagic Retinal Vasculitis: Clinical Course and Treatment
dc.typeBildiri
dc.contributor.departmentÄ°stanbul Üniversitesi , Ä°stanbul Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü
dc.contributor.firstauthorID3418453


Bu öÄŸenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öÄŸe ile iliÅŸkili dosya yok.

Bu öÄŸe aÅŸağıdaki koleksiyon(lar)da görünmektedir.

Basit öÄŸe kaydını göster